Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2008
11/06/2008CA2682889A1 Antibodies that bind both il-17a and il-17f and methods of using the same
11/06/2008CA2669315A1 Ablative immunotherapy
11/06/2008CA2669049A1 Binary epitope antibodies and b cell superantigen immune stimulants
11/05/2008EP1988166A1 Human Toll-like receptor proteins, related reagents and methods
11/05/2008EP1988165A1 Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same
11/05/2008EP1988164A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor
11/05/2008EP1988162A1 Monoclonal antibody, gene encoding the antibody, hybridoma, pharmaceutical composition, and diagnostic reagent
11/05/2008EP1988103A2 Tyrosine phosphorylation sites and antibodies specific for them
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer
11/05/2008EP1988094A1 Hapten compound and antibody
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987839A1 Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
11/05/2008EP1987359A2 Vascular tumor markers
11/05/2008EP1987161A2 Method to identify cd40-sensitive cells
11/05/2008EP1987139A2 Novel oxidoreductases and uses thereof
11/05/2008EP1987138A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
11/05/2008EP1987067A2 Antibody formulation
11/05/2008EP1987066A2 Methods for treating autoimmune or demyelinating diseases
11/05/2008EP1987065A2 Methods for improving immune function and methods for prevention or treatment of disease in a mammalian subject
11/05/2008EP1987064A1 Domain antibody construct
11/05/2008EP1987059A2 Adir related polymorphisms and applications thereof
11/05/2008EP1987058A1 Soluble il-17rcx4 and methods of using in inflammation
11/05/2008EP1986698A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
11/05/2008EP1986690A2 ANTI-FcRn ANTIBODIES FOR TREATEMENT OF AUTO/ALLO IMMUNE CONDITIONS
11/05/2008EP1986689A2 Compositions and methods for treating haematological proliferative disorders
11/05/2008EP1986688A2 Methods of using antibodies against human il-22
11/05/2008EP1986687A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
11/05/2008EP1848831A4 Elisa assays using prion-specific peptide reagents
11/05/2008EP1728077A4 Method for determination and quantification of radiation or genotoxin exposure
11/05/2008EP1646720B1 Antibodies against insulin-like growth factor i receptor and uses thereof
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1140172B1 The prevention and treatment for retinal ischemia and edema
11/05/2008EP1109937B1 METHOD OF DIAGNOSING, MONITORING, STAGING, and IMAGING VARIOUS CANCERS
11/05/2008EP0994724B1 Methods and compositions for impairing multiplication of hiv-1
11/05/2008CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response
11/05/2008CN101300274A Immunomodulatory compositions and uses therefor
11/05/2008CN101300273A TRAIL recipient 2 Polypeptides and antibodies
11/05/2008CN101300272A Compositions and methods for treating proliferative disorders
11/05/2008CN101300024A Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/05/2008CN101300021A Antibodies and uses thereof
11/05/2008CN101298615A Novel anti-plasmodium falciparum epitope and vaccine containing the same
11/05/2008CN101298613A Transforming growth factor alpha-HII
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298480A Human
11/05/2008CN101298479A Antibodies for inhibiting blood coagulation and methods of use thereof
11/05/2008CN100430727C Assaying protein fragments in body fluids
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430473C Hybrid tumor cell strain and its produced human alpha-galactosidase A resisting monoclonal antibody
11/05/2008CN100430420C Human CDR-grafted antibodies and antibody fragments thereof
11/05/2008CN100430419C Anti-CD40 monoclonal antibody
11/05/2008CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
11/04/2008US7446190 Nucleic acids encoding chimeric T cell receptors
11/04/2008US7446182 Recombinant antibodies for the detection and neutralization of anthrax toxin
11/04/2008US7446181 Antibodies that bind human Dickkopf-1 proteins
11/04/2008US7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446178 For treament of neoplasia; competitive binding; kits
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7446176 Of given amino acid sequence; bind to antibodies; detecting integrin; diagnosing and treating disorders
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446171 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers,
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446095 Peptides modulating caspase activation
11/04/2008US7445920 Member of the lysyl oxidase gene family
11/04/2008US7445913 Recombinant cell comprising expression vector; transcription; new cytokine that stimulates hematopoietic cells
11/04/2008US7445912 Stabilized proteins
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445901 Admixing with monoclonal antibodies; binds to ribonuclease; DNA or RNA maintains its intact, full-length form during production and storage
11/04/2008US7445798 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo
11/04/2008US7445794 Administering 2-deoxy-D-glucose and etomoxir and anti-Fas antibody for cancer therapy
11/04/2008US7445788 Polypeptide for use in the diagnosis and detection of bacterial infections
11/04/2008US7445782 Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445779 Methods of modulating IFNy production
11/04/2008US7445778 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor
11/04/2008CA2486330C Stress-responsive root-specific genes
11/04/2008CA2330186C Divalent antibody fragments
10/2008
10/30/2008WO2008131406A2 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5
10/30/2008WO2008131376A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/30/2008WO2008131298A2 Prevention and treatment of cerebral amyloid angiopathy
10/30/2008WO2008131242A1 Single chain fc, methods of making and methods of treatment
10/30/2008WO2008130969A2 Novel compounds
10/30/2008WO2008130704A2 PDGFRβ-SPECIFIC INHIBITORS
10/30/2008WO2008130204A1 New anti-irc85 monoclonal antibody; and composition comprising the same for preventing and treating tuberculosis or enteritis disease; and the use thereof
10/30/2008WO2008130034A1 Polyamino acid synthetase and gene encoding the same
10/30/2008WO2008129896A1 Method of diagnosing asthenospermia
10/30/2008WO2008129838A1 Germ cell marker using fish vasa gene
10/30/2008WO2008129263A1 Antibodies against il-25
10/30/2008WO2008129124A1 Novel fully human anti-vap-1 monoclonal antibodies
10/30/2008WO2008128701A2 Yeast expression systems
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008128330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008WO2008110653B1 Antibody producing microorganism, elements required to obtain same, resulting antibodies, therapeutic compositions and use of thereof
10/30/2008WO2008110379A3 Monoclonal antibodies for treatment of cancer
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008109332A3 Methods and compositions for determining the efficacy of breast cancer therapeutics
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 1494